Monday 25 September 2017

Nylon 6 & 66 market Projected to reach USD 41.13 billion by 2025 : Grand View Research,Inc.

The global nylon 6 & 66 market is expected to reach USD 41.13 billion by 2025, according to a new report by Grand View Research, Inc.The market is expected to witness growth at 6.1% CAGR owing to Increasing focus on fuel efficient and less polluting vehicles has forced the manufacturers to shift their focus from metals to plastics. Nylon being lightweight and heat resistant, has caught the attention of auto-manufacturers. Extensive demand from automotive industry is expected to trigger the nylon market growth. 
Nylon 6 holds the largest consumption share in the total nylon resin market, with most of the demand being generated from the textile industry. However, there is an increasing trend of nylon 66 consumption from the engineering plastic industry which is rampantly using nylon 66 to manufacture plastic products, replacing PVC.
There has been a disruption in the supply chain of the nylon value chain, as raw material caprolactam was oversupplied by the Asian manufacturers in the market. This trend had an adverse effect on the caprolactam prices resulting in shutdown of manufacturing units in North America and Europe.
Nylon 6 and 66 prices witnessed an increase in 2017 but are expected to hold stable in the forecasted years. Asia is predicted to hold a strong presence in the nylon 6 value chain while North America will successfully stabilize its nylon 66 capacity in the forecasted period.
Browse full report by Grand View Research:
Further key findings from the report suggest:
·         Nylon-6 dominates the global market with around 60% of total demand in 2016
·         Nylon demand from automotive segment to reach a valuation of USD 11.26 billion by 2025. Increasing adaptation of nylon 66 in engineering plastics to replace traditional plastic has been responsible for the market growth.
·         Consumption of nylon (6 and 66) resins is expected to reach 2.8 million tons by 2025 in Europe alone
·         Caprolactam production and consumption in Asia Pacific is expected to increase as key nylon manufacturers in the region are expanding their production capacity
·         Nylon manufacturers are showing a trend of backward and forward integration to attain mature position in the nylon market
·         Asia Pacific is the epicenter of nylon 6 production whereas Europe and North America are expected to attain a strong hold in the nylon 66 market by the end of 2025
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry-analysis/nylon-6-6-market
Grand View Research has segmented the global nylon 6 & 66 market on the basis of product, application, and region:
Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         Nylon 6
·         Nylon 66
Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         Automobile        
·         Electrical & electronic
·         Engineering plastics
·         Textile
·         Others
Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
·         Europe  
o    Germany
o    France
o    UK
·         Asia-Pacific
o    China
o    India
o    Japan
o    South Korea
·         MEA
·         CSA
About Grand View Research                                                                                                     Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com








at No comments:

Interventional cardiology devices market Projected to reach USD 25.16 billion by 2020 : Grand View Research,Inc

The global interventional cardiologydevices market is expected to reach USD 25.16 billion by 2020, according to a new report by Grand View Research. Increasing prevalence of cardiovascular diseases coupled with adoption of minimally invasive surgeries is expected to boost the interventional cardiology device market over the forecast period. Unhealthy lifestyle habits such as high alcohol consumption, smoking, and lack of physical exercise are triggering incidences of cardiovascular diseases. Furthermore, the number of congenital heart disease patients is on a constant rise and this acts as a growth driver for the market.
Browse full report by Grand View Research:
According to a report published by the U.S. CDC (Centers for Disease Control and Prevention) in 2011, congenital heart defects are the most common birth defects in the U.S., affecting approximately 1% of the births every year. The treatment of cardiovascular disorders has changed dramatically due to the introduction of new drug therapies and devices such as guidewires and stents allowing the patient to live better quality and longer lives.
The advent of technologically advanced internal substitutes plays an integral role in this market and manufacturers focus on developing new products to curb problems associated with previous versions. For example, the evolution of stents began from bare metal stents and has now reached a completely new horizon in the form of disappearing stents (bio-absorbable stents). Stents accounted for over 70% market share primarily owing to high usage rates in 2013.
Catheters in sync with stent are expected to register steady growth to reach up to a market size of over USD 2.5 billion in 2020. The growth is primarily driven by primarily the rising demand for minimally invasive medical procedures in the field of cardiovascular diseases. Faster patient recovery time and lesser procedure duration are two most significant factors contributing towards the rising demand of these medical procedures.
The North America interventional cardiology device market in 2013 was valued at over USD 5.5 billion, owing to factors such as the presence of favorable government initiatives encouraging new product development, sophisticated healthcare infrastructure and increasing patient awareness levels coupled with relatively higher healthcare expenditures in the region.
On the other hand, the Asia Pacific market is expected to reach over USD 6.4 billion by 2022, growing at a lucrative rate over the forecast period. The growth is attributed to the presence of large untapped opportunities, rising healthcare expenditure, cardiovascular disease incidence rate, and disposable income levels. Prominent players operating in this industry includes Cordis Corporation, Abbott Laboratories, Medtronic, Inc, Terumo Medical Corporation, B. Braun Melsungen AG, and Boston Scientific.
About Grand View Research                                                                                                     Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com










at No comments:

Poultry diagnostics market Anticipated to reach USD 771.4 million by 2025 : Grand View Research,Inc.

The global poultrydiagnostics market is expected to reach USD 771.4 million by 2025, growing at a CAGR of 9.6%, according to a new report by Grand View Research, Inc. Disease outbreaks, technological advancements, and supportive government initiatives are the key drivers for the substantial growth of poultry diagnostic market. With the outbreak of catastrophic and erosive diseases such as Avian Influenza, Newcastle disease, and other respiratory infections, the farmers are now opting for a preventive diagnosis. These flock-infections are affecting the global trade of layers, broilers, turkeys, and water fowl. As a result, there have been continuous efforts to increase the awareness about these diseases, amongst poultry farmers.
Technological advancements in animal health are the key driver and is expected to serve as future growth opportunities. The advent of efficient animal owner’s mobile technology, information management systems and vaccine banks are the key advancements. The rising number of government initiatives to promote animal health products is presumed to drive the overall market growth during the forecast period.
For instance, the World Organization for Animal Health (OIE) International Standards, a part of World Trade Organization (WTO) framework, issues guidelines to improve animal health and promote international animal products trade. The measures facilitate early detection, control, and reporting of pathogenic agents and prevent their transmission by rejecting of products which are not matching the standards.
Browse full report by Grand View Research:
Further key findings from the study suggest:
·         The ELISA tests contributed to more than 57.0% share in 2016. This can be attributed to their high sensitivity, specificity, accuracy and cost-efficinecy.
·         Avian influenza led this industry with more than 24.0% share in 2016. Frequent outbreaks of influenza (bird flu) in Southeast Asian and African countries contributed to the substantial share.
·         North America led global poultry diagnostic market with more than 35.0% share in 2016. This can be attributed to their advanced infrastructure pertaining to animal health, extensive distribution network, presence of multinational players and increasing awareness amongst farmers.
·         Zoetis, QIAGEN, IDvet, Biocheck Smart Veterinary Diagnostics, Bioneer Corporation, Thermo Fisher Scientific Inc., BioinGentech Biotechnology company, MEGACOR Diagnostik GmbH, IDEXX Laboratories, Inc., and AffiniTech, LTD. are few of the key players in poultry diagnostics market.
·         New product developments, collaborations, regional expansion, and mergers are key strategic initiatives undertaken.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the poultry diagnostics market by test types, disease types and region:
Poultry Diagnostics Test Types Outlook (Revenue, USD Million; 2014 - 2025)
·         ELISA
·         PCR
·         Others
Poultry Diagnostics Disease Types Outlook (Revenue, USD Million; 2014 - 2025)
·         Avian Salmonellosis
·         Avian Influenza
·         Newcastle Disease
·         Avian Mycoplasmosis
·         Infectious Bronchitis
·         Infectious Bursal Disease
·         Avian Pasteurellosis
·         Avian Encephalomyelitis
·         Avian Reovirus
·         Chicken Anemia
·         Other Diseases
Poultry Diagnostics Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    France
o    UK
o    Poland
o    Denmark
o    Italy
·         Asia Pacific
o    China
o    India
·         Latin America
o    Brazil
o    Argentina
·         MEA
o    South Africa
o    Saudi Arabia
About Grand View Research                                                                                                     Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com






at No comments:

Anesthesia monitoring devices market Expected to reach USD 1.9 billion by 2024 : Grand View Research,Inc.

The anesthesia monitoring devices market is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications.
The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period.
Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, microprocessor-based intelligent anesthesia systems with integrated monitors enables monitoring of various parameters along with the precisely-controlled administration of the anesthetic agent.
Browse full report by Grand View Research: 
Further key findings from the study suggest:
·         Amongst the product type segments, the advanced anesthesia monitors segment held a lucrative share of over 60.0% in 2015 owing to its durability, reliability, and accuracy. Moreover, these devices monitor various significant parameters such as oxygen saturation level, carbon dioxide level, heart rate, and blood pressure.
·         The hospitals in the end-use segment exhibited remunerative growth in 2015; this can be attributed to the presence of advanced diagnostic and therapeutic medical technologies that enables both, faster and accurate diagnosis. Moreover, the availability of these advanced systems coupled with the presence of skilled personnel contributes towards profitable growth of this segment.
·         North America dominated the overall market with a revenue share of over 35.0% in 2015 owing to the presence of well-developed health care settings and the presence of a favorable reimbursement network, government funding, and increasing health awareness levels amongst the people.
·         However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 11.0% over the forecast period. The economic developments and the advancing healthcare system with the aid of supportive government initiatives are collectively anticipated to further assist the growth in this region.
·         Some key players operating in the anesthesia monitoring devices market include Masimo Corporation, Infinium Medical, Inc., Medtronic plc, GE Healthcare, Nihon Kohden Corporation, Philips Healthcare, Mindray Medical International Ltd., Drägerwerk AG & Co. KGaA, and Schiller AG. New product development, mergers, and collaborations are some key initiatives taken to sustain themselves in the competition.
·         For instance, Masimo Corporation incorporated Oxygen Reverse Index (ORI) which measures the oxygen levels and provides real-time information with regard to the patient’s oxygen reserve in synchronization with the partial pressure of oxygen to prevent hyperoxia conditions (oxygen levels above normal) in patients that are receiving auxiliary oxygen supply whilst undergoing surgery.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented anesthesia monitoring devices market on the basis of product type, end-use, and region.
Global Anesthesia Monitoring Devices Market By Product Revenue, (USD Million) 2013 - 2024
·         Advanced Anesthesia Monitors
o    Anesthesia Gas Monitors
o    Monitors Measuring Depth of Anesthesia
o    Standalone Capnography Monitors
o    Others
·         Basic Anesthesia Monitors
·         Integrated Anesthesia Monitors
Global Anesthesia Monitoring Devices Market By End-Use Revenue, (USD Million) 2013 - 2024
·         Hospitals
·         Ambulatory Settings
·         Others
Anesthesia Monitoring Devices Market By Region Revenue, (USD Million) 2013 - 2024
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
o    Saudi Arabia

About Grand View Research                                                                                                     Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com





at No comments:
Subscribe to: Posts (Atom)